Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: Entanglement
Top Cited Papers
- 29 May 2003
- Vol. 326 (7400) , 1189-1192
- https://doi.org/10.1136/bmj.326.7400.1189
Abstract
In this two part article, a journalist based in Washington DC explores the brewing conflicts at one of the world9s leading medical campuses as it joins the wider global debate about how to redefine relations with big pharmaceutical companiesKeywords
This publication has 14 references indexed in Scilit:
- All Gifts Large and SmallAmerican Journal of Bioethics, 2003
- Medical journals and pharmaceutical companies: uneasy bedfellowsBMJ, 2003
- Pharmaceutical industry sponsorship and research outcome and quality: systematic reviewBMJ, 2003
- Italian police investigate GSK Italy for briberyBMJ, 2003
- Scope and Impact of Financial Conflicts of Interest in Biomedical ResearchJAMA, 2003
- America's other drug problem: how the drug industry distorts medicine and politics.2002
- Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotionsThe American Journal of Medicine, 2001
- Assessing Faculty Financial Relationships With IndustryJAMA, 2000
- Is Academic Medicine for Sale?New England Journal of Medicine, 2000
- Physicians and the Pharmaceutical IndustryJAMA, 2000